• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolones and derivatives

Comprehensive Overview of 7-Fluoro-2-Methoxyquinoline (CAS No. 885688-32-4): Properties, Applications, and Industry Insights

7-Fluoro-2-methoxyquinoline (CAS No. 885688-32-4) is a fluorinated quinoline derivative that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural features. The compound's molecular formula, C₁₀H₈FNO, combines a quinoline backbone with a fluoro substituent at the 7-position and a methoxy group at the 2-position, rendering it a versatile intermediate for drug discovery. Recent studies highlight its potential in modulating biological targets, particularly in the development of kinase inhibitors and antimicrobial agents.

In the context of trending topics, researchers are increasingly exploring fluorinated heterocycles like 7-fluoro-2-methoxyquinoline for their enhanced metabolic stability and bioavailability—a critical consideration in modern drug design. Searches for "fluoroquinoline derivatives in drug discovery" and "CAS 885688-32-4 applications" have surged by 40% year-over-year, reflecting growing industrial interest. The compound’s lipophilic efficiency (LipE) and hydrogen-bonding capacity make it a promising scaffold for CNS-targeted therapies, aligning with the demand for neurodegenerative disease treatments.

From a synthetic chemistry perspective, 885688-32-4 serves as a key building block in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings. Its electron-deficient quinoline ring facilitates regioselective functionalization, a feature exploited in creating libraries of analogs for high-throughput screening. Laboratories often inquire about "synthetic routes to 7-fluoro-2-methoxyquinoline" or "scale-up protocols for CAS 885688-32-4," underscoring its practical relevance in process chemistry.

Environmental and regulatory considerations also shape discussions around this compound. With the FDA emphasizing green chemistry principles, manufacturers are optimizing synthetic pathways to minimize waste generation during 7-fluoro-2-methoxyquinoline production. Analytical methods like HPLC purity analysis and residual solvent testing are frequently searched in conjunction with this CAS number, highlighting quality control priorities.

Emerging applications in material science further expand the utility of 7-fluoro-2-methoxyquinoline. Its π-conjugated system shows promise in organic light-emitting diodes (OLEDs), with patents citing derivatives for electron-transport layers. This interdisciplinary potential answers frequent queries about "quinoline-based electronic materials" and "CAS 885688-32-4 in optoelectronics," bridging pharmaceutical and advanced material sectors.

Market analytics reveal that 885688-32-4 maintains steady demand across North America and Asia-Pacific regions, driven by R&D investments in precision medicine. Suppliers increasingly provide GMP-grade 7-fluoro-2-methoxyquinoline to meet clinical trial requirements, addressing search trends like "pharmaceutical intermediates suppliers" and "high-purity fluorinated quinolines." Storage recommendations typically emphasize protection from light and moisture to preserve stability.

In summary, 7-fluoro-2-methoxyquinoline (CAS No. 885688-32-4) exemplifies the convergence of medicinal chemistry and advanced materials science. Its dual functionality as a pharmacophore and material precursor ensures sustained relevance, while evolving synthetic and analytical methodologies address both efficacy and sustainability imperatives in modern chemical industries.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)